PUK trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes PUK achieves its forward estimates and maintains a stable P/E multiple of 10.7x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 29, 2026, Prudential plc (PUK) has a Wall Street consensus price target of N/A, based on estimates from 8 covering analysts. The company has a market capitalization of $33.57B.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, PUK trades at a trailing P/E of 8.8x and forward P/E of 10.7x. Analysts expect EPS to grow -42.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $39.70, with bear and bull scenarios of $25.01 and $52.31 respectively. Model confidence stands at 40/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MFCManulife Financial Corporation | $67.6B | $40.29 | $34.24 | -15.0% | Buy | 9.0x | 14 |
SLFSun Life Financial Inc. | $43.1B | $77.89 | $81.00 | +4.0% | Hold | 13.9x | 15 |
EQHEquitable Holdings, Inc. | $12.4B | $44.00 | $58.57 | +33.1% | Buy | 6.2x | 21 |
PRUPrudential Financial, Inc. | $37.7B | $108.25 | $98.71 | -8.8% | Hold | 7.9x | 37 |
METMetLife, Inc. | $56.0B | $85.95 | $94.86 | +10.4% | Buy | 8.7x | 33 |
LNCLincoln National Corporation | $7.0B | $36.72 | $41.00 | +11.7% | Hold | 4.8x | 28 |
AFLAflac Incorporated | $61.2B | $120.15 | $115.17 | -4.1% | Hold | 17.0x | 32 |
GLGlobe Life Inc. | $13.9B | $179.31 | $174.50 | -2.7% | Hold | 11.5x | 28 |
PFGPrincipal Financial Group, Inc. | $23.3B | $107.75 | $102.43 | -4.9% | Hold | 11.5x | 25 |
CRBGCorebridge Financial, Inc. | $13.1B | $28.61 | $32.00 | +11.8% | Buy | 6.1x | 18 |
Quick answers to the most common questions about buying PUK stock.
The consensus price target for PUK is $N/A, close to the current price of $26.62 (N/A% implied move). Based on 8 analyst estimates, the stock appears fairly valued near current levels.
PUK has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 10.7339x, PUK trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for PUK, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $52 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
PUK is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 3 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PUK stock forecast based on 8 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $40, with bear/bull scenarios of $25/$52.
Our quantitative valuation model calculates PUK's fair value at $40 (base case), with a bear case of $25 and bull case of $52. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 40/100.
PUK trades at a forward P/E ratio of 10.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 8.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
PUK appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PUK analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $25-$52 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.